Bionika Pharmaceuticals has production capacity on annual level, functioning in one shift from:
- 2.5 million blisters with tablets or capsules (tertiary production – primary, secondary and tertiary packing);
- 750 000 suppositories or pessaries (secondary and tertiary production);
- 300 000 tubes of ointments, creams and gels (secondary and tertiary production);
- 300,000 bottles of solutions for internal or external administration
